FDA DEVICE FACTS
Sapphire® Spinal System, Sapphire X Anterior Cervical Plate Spinal System
Spinal Elements, Inc.
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
The Sapphire® Spinal is intended for anterior cervical fixation (C2-T1) in skeletally mature patients as an adjunct to fusion for the following indications:
• Degenerative Disc Disease (defined as neck pain of discogenic origin with degeneration of the disc confirmed by history and radiographic studies)
• Spondylolisthesis
• Trauma (including fracture or dislocation)
• Spinal stenosis
• Deformities or Curvatures (kyphosis, lordosis or scoliosis)
• Tumor
• Pseudoarthrosis
• Failed previous fusion
The Sapphire X Anterior Cervical Plate Spinal System is intended for anterior cervical fixation (C2-T1) in skeletally mature patients as an adjunct to fusion for the following indications:
• Degenerative Disc Disease (defined as neck pain of discogenic origin with degeneration of the disc confirmed by history and radiographic studies)
• Spondylolisthesis
• Trauma (including fracture or dislocation)
• Spinal stenosis
• Deformities or Curvatures (kyphosis, lordosis or scoliosis)
• Tumor
• Pseudoarthrosis
• Failed previous fusion Page 3 of 3 Spinal Elements, Inc. Premarket Notification – Sapphire® and Sapphire X Spinal Systems
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。